Astellas launches Astagraf XL in U.S. for prophylaxis of organ rejection after kidney transplant Aug. 23, 2013
Teva obtains European approval for Lonquex to help manage neutropenia during chemotherapy Aug. 9, 2013
FDA approves Gilotrif along with companion diagnostic for first-line treatment of metastatic NSCLC July 15, 2013